Forward Price: The price at which a synthetic long stock position (i.e., buying an at-the-money call and selling an at-the-money put) would break even at expiration.
Prelude Therapeutics Incorporated (PRLD) had 30-Day Forward Price of 4.19 for 2024-05-16.